董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Teddie Wardi | 男 | Director | 40 | 未披露 | 未持股 | 2025-03-31 |
| Daniel Perez | 男 | Chief Executive Officer, Co-Founder and Director | 39 | 4581.21万美元 | 1055.17 | 2025-03-31 |
| Gabriel Mecklenburg | 男 | Executive Chairman, Co-Founder and Director | 36 | 50.00万美元 | 402.60 | 2025-03-31 |
| Kristina Leslie | 女 | Director | 60 | 4.58万美元 | 0.88 | 2025-03-31 |
| Elliott Robinson | 男 | Director | 40 | 未披露 | 未持股 | 2025-03-31 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Daniel Perez | 男 | Chief Executive Officer, Co-Founder and Director | 39 | 4581.21万美元 | 1055.17 | 2025-03-31 |
| Jim Pursley | 男 | President | 45 | 369.18万美元 | 60.47 | 2025-03-31 |
| Gabriel Mecklenburg | 男 | Executive Chairman, Co-Founder and Director | 36 | 50.00万美元 | 402.60 | 2025-03-31 |
| James Budge | 男 | Chief Financial Officer | 58 | 344.90万美元 | 17.23 | 2025-03-31 |
董事简历
中英对照 | 中文 | 英文- Teddie Wardi
-
Teddie Wardi自2019年5月以来一直担任我们的董事会成员。自2017年10月以来，Wardi先生一直担任私人投资公司Insight Venture Management，L.L.C.的董事总经理。在加入Insight之前，Wardi先生于2016年3月至2017年10月担任国际投资公司Atomico UK Partners LLP的合伙人。此前，2014年3月至2016年3月，Wardi先生担任私人投资公司Dawn Capital LLP的副总裁。Wardi先生共同创立了Nervogrid Oy，这是一家被Also Holding AG收购的软件提供商，并于2006年3月至2012年8月担任首席技术官。Wardi先生拥有芬兰阿尔托大学的商业技术与金融学士学位和哈佛商学院的工商管理硕士学位。
Teddie Wardi has served as a member of Sentinelone, Inc.'s Board since May 2019. Since January 2018, Mr. Wardi has served as a Managing Director at Insight Venture Management, L.L.C., a private investment firm. Prior to joining Insight, Mr. Wardi served as a Partner at Atomico (UK) Partners LLP, an international investment firm, from March 2016 to October 2017. Previously, Mr. Wardi served as Vice President at Dawn Capital LLP, a private investment firm, from March 2014 to March 2016. Mr. Wardi co founded Nervogrid Oy, a software provider acquired by ALSO Holding Ag, and served as Chief Technology Officer from March 2006 to August 2012. Mr. Wardi has also served on the board of directors of Hinge Health, Inc., a healthcare technology company, since November 2018. Mr. Wardi holds a B.S.c. Business Technology and Finance from Aalto University in Finland and an M.B.A. from Harvard Business School. - Teddie Wardi自2019年5月以来一直担任我们的董事会成员。自2017年10月以来，Wardi先生一直担任私人投资公司Insight Venture Management，L.L.C.的董事总经理。在加入Insight之前，Wardi先生于2016年3月至2017年10月担任国际投资公司Atomico UK Partners LLP的合伙人。此前，2014年3月至2016年3月，Wardi先生担任私人投资公司Dawn Capital LLP的副总裁。Wardi先生共同创立了Nervogrid Oy，这是一家被Also Holding AG收购的软件提供商，并于2006年3月至2012年8月担任首席技术官。Wardi先生拥有芬兰阿尔托大学的商业技术与金融学士学位和哈佛商学院的工商管理硕士学位。
- Teddie Wardi has served as a member of Sentinelone, Inc.'s Board since May 2019. Since January 2018, Mr. Wardi has served as a Managing Director at Insight Venture Management, L.L.C., a private investment firm. Prior to joining Insight, Mr. Wardi served as a Partner at Atomico (UK) Partners LLP, an international investment firm, from March 2016 to October 2017. Previously, Mr. Wardi served as Vice President at Dawn Capital LLP, a private investment firm, from March 2014 to March 2016. Mr. Wardi co founded Nervogrid Oy, a software provider acquired by ALSO Holding Ag, and served as Chief Technology Officer from March 2006 to August 2012. Mr. Wardi has also served on the board of directors of Hinge Health, Inc., a healthcare technology company, since November 2018. Mr. Wardi holds a B.S.c. Business Technology and Finance from Aalto University in Finland and an M.B.A. from Harvard Business School.
- Daniel Perez
-
Daniel Perez，是联合创始人，自2012年1月起担任首席执行官和董事会成员。在加入Hinge Health之前，Perez先生于2011年6月至2016年5月担任全球生物技术研究平台Oxbridge Biotech Roundtable Ltd.的联合创始人兼首席执行官。Perez先生拥有威斯敏斯特大学生物学学士学位。
Daniel Perez,is co-founder and has served as Chief Executive Officer and a member of board of directors since January 2012. Prior to joining Hinge Health, Mr. Perez was the co-founder and Chief Executive Officer at Oxbridge Biotech Roundtable Ltd., a global biotechnology research platform, from June 2011 to May 2016. Mr. Perez holds a B.S. in Biology from Westminster University. - Daniel Perez，是联合创始人，自2012年1月起担任首席执行官和董事会成员。在加入Hinge Health之前，Perez先生于2011年6月至2016年5月担任全球生物技术研究平台Oxbridge Biotech Roundtable Ltd.的联合创始人兼首席执行官。Perez先生拥有威斯敏斯特大学生物学学士学位。
- Daniel Perez,is co-founder and has served as Chief Executive Officer and a member of board of directors since January 2012. Prior to joining Hinge Health, Mr. Perez was the co-founder and Chief Executive Officer at Oxbridge Biotech Roundtable Ltd., a global biotechnology research platform, from June 2011 to May 2016. Mr. Perez holds a B.S. in Biology from Westminster University.
- Gabriel Mecklenburg
-
Gabriel Mecklenburg是联合创始人，自2021年2月起担任公司执行主席，自2016年3月起担任董事会成员。他还在2014年10月至2021年2月期间担任首席运营官。2011年12月至2014年5月，梅克伦堡先生担任全球生物技术研究平台Oxbridge Biotech Roundtable Ltd.的首席运营官。自2022年1月以来，他一直担任Digital Therapeutics，Inc.的董事会成员，从事Pelago Health的业务，这是一家私营虚拟护理公司，专注于物质Hinge Health，Inc. e管理。梅克伦堡先生拥有剑桥大学材料科学硕士学位和伦敦帝国理工学院生物工程硕士学位。
Gabriel Mecklenburg,is co-founder and has served as the Executive Chairman of company since February 2021 and a member of board of directors since March 2016. He also served as Chief Operating Officer from October 2014 to February 2021. From December 2011 to May 2014, Mr. Mecklenburg was the Chief Operating Officer at Oxbridge Biotech Roundtable Ltd., a global biotechnology research platform. He has served on the board of directors of Digital Therapeutics, Inc., doing business as Pelago Health, a privately held virtual care company focused on substance Hinge Health, Inc. e management, since January 2022. Mr. Mecklenburg holds an M.Sc. in Materials Science from the University of Cambridge and an M.Phil. in Bioengineering from Imperial College London. - Gabriel Mecklenburg是联合创始人，自2021年2月起担任公司执行主席，自2016年3月起担任董事会成员。他还在2014年10月至2021年2月期间担任首席运营官。2011年12月至2014年5月，梅克伦堡先生担任全球生物技术研究平台Oxbridge Biotech Roundtable Ltd.的首席运营官。自2022年1月以来，他一直担任Digital Therapeutics，Inc.的董事会成员，从事Pelago Health的业务，这是一家私营虚拟护理公司，专注于物质Hinge Health，Inc. e管理。梅克伦堡先生拥有剑桥大学材料科学硕士学位和伦敦帝国理工学院生物工程硕士学位。
- Gabriel Mecklenburg,is co-founder and has served as the Executive Chairman of company since February 2021 and a member of board of directors since March 2016. He also served as Chief Operating Officer from October 2014 to February 2021. From December 2011 to May 2014, Mr. Mecklenburg was the Chief Operating Officer at Oxbridge Biotech Roundtable Ltd., a global biotechnology research platform. He has served on the board of directors of Digital Therapeutics, Inc., doing business as Pelago Health, a privately held virtual care company focused on substance Hinge Health, Inc. e management, since January 2022. Mr. Mecklenburg holds an M.Sc. in Materials Science from the University of Cambridge and an M.Phil. in Bioengineering from Imperial College London.
- Kristina Leslie
-
Kristina Leslie，自2024年4月起担任董事会成员。Leslie女士此前于2004年至2007年在多媒体动画公司DreamWorks Animation SKG Inc.担任首席财务官。在过去15年里，莱斯利女士曾在多个公共和私人董事会任职。目前，Leslie女士担任公众持有的住宿房地产投资信托基金Sunstone Hotel Investors, Inc.和私营人力资源技术公司Justworks, Inc.的董事会成员，并且是健康计划公司Blue Shield of California的董事会主席。在此之前，Leslie女士还曾在其他几家上市公司的董事会任职，包括2021年7月至2024年2月期间在Leslie's女士担任董事期间上市的宠物护理公司Rover Group公司、2015年至2022年期间在银行控股公司TERMB Financial CVB金融 Corp.、2009年至2016年在水资源和存储公司Pico Holdings Inc.、2011年至2015年在旅行搜索和票价聚合公司Orbitz Worldwide, Inc.、2012年至2013年在护肤品公司Obagi Medical Products以及2007年至2010年在化妆品公司Bare Escentuals Inc.任职。此外，Leslie女士此前曾在多家私营公司的董事会任职，包括2015年至2018年的Glassdoor Inc.和2007年至2013年的南加州卫理公会医院。Leslie女士拥有哥伦比亚大学商学院的工商管理硕士学位和巴克内尔大学的经济学学士学位。
Kristina Leslie,has served as a member of board of directors since April 2024. Ms. Leslie previously served as Chief Financial Officer of DreamWorks Animation SKG Inc., a multimedia animation company, from 2004 to 2007. Over the past 15 years, Ms. Leslie has served on a number of public and private boards. Currently, Ms. Leslie serves as a member of the board of directors of Sunstone Hotel Investors, Inc., a publicly held lodging real estate investment trust, and Justworks, Inc., a private human resource technology company, and is the chair of the board of directors of Blue Shield of California, a health plan company. Previously, Ms. Leslie served on the boards of several other publicly held companies, including Rover Group, Inc. from July 2021 to February 2024, a pet care company that was public during Ms. Leslie's tenure as director, CVB Financial Corp. from 2015 to 2022, a bank holding company, Pico Holdings Inc., a water resources and storage company, from 2009 to 2016, Orbitz Worldwide, Inc., a travel search and fare aggregator company, from 2011 to 2015, Obagi Medical Products, a skin care company, from 2012 to 2013, and Bare Escentuals Inc., a cosmetics company, from 2007 to 2010. Additionally, Ms. Leslie has previously served on the boards of several private companies, including Glassdoor Inc. from 2015 to 2018 and Methodist Hospital of Southern California from 2007 to 2013. Ms. Leslie holds an M.B.A. from Columbia Business School and a B.A. in Economics from Bucknell University. - Kristina Leslie，自2024年4月起担任董事会成员。Leslie女士此前于2004年至2007年在多媒体动画公司DreamWorks Animation SKG Inc.担任首席财务官。在过去15年里，莱斯利女士曾在多个公共和私人董事会任职。目前，Leslie女士担任公众持有的住宿房地产投资信托基金Sunstone Hotel Investors, Inc.和私营人力资源技术公司Justworks, Inc.的董事会成员，并且是健康计划公司Blue Shield of California的董事会主席。在此之前，Leslie女士还曾在其他几家上市公司的董事会任职，包括2021年7月至2024年2月期间在Leslie's女士担任董事期间上市的宠物护理公司Rover Group公司、2015年至2022年期间在银行控股公司TERMB Financial CVB金融 Corp.、2009年至2016年在水资源和存储公司Pico Holdings Inc.、2011年至2015年在旅行搜索和票价聚合公司Orbitz Worldwide, Inc.、2012年至2013年在护肤品公司Obagi Medical Products以及2007年至2010年在化妆品公司Bare Escentuals Inc.任职。此外，Leslie女士此前曾在多家私营公司的董事会任职，包括2015年至2018年的Glassdoor Inc.和2007年至2013年的南加州卫理公会医院。Leslie女士拥有哥伦比亚大学商学院的工商管理硕士学位和巴克内尔大学的经济学学士学位。
- Kristina Leslie,has served as a member of board of directors since April 2024. Ms. Leslie previously served as Chief Financial Officer of DreamWorks Animation SKG Inc., a multimedia animation company, from 2004 to 2007. Over the past 15 years, Ms. Leslie has served on a number of public and private boards. Currently, Ms. Leslie serves as a member of the board of directors of Sunstone Hotel Investors, Inc., a publicly held lodging real estate investment trust, and Justworks, Inc., a private human resource technology company, and is the chair of the board of directors of Blue Shield of California, a health plan company. Previously, Ms. Leslie served on the boards of several other publicly held companies, including Rover Group, Inc. from July 2021 to February 2024, a pet care company that was public during Ms. Leslie's tenure as director, CVB Financial Corp. from 2015 to 2022, a bank holding company, Pico Holdings Inc., a water resources and storage company, from 2009 to 2016, Orbitz Worldwide, Inc., a travel search and fare aggregator company, from 2011 to 2015, Obagi Medical Products, a skin care company, from 2012 to 2013, and Bare Escentuals Inc., a cosmetics company, from 2007 to 2010. Additionally, Ms. Leslie has previously served on the boards of several private companies, including Glassdoor Inc. from 2015 to 2018 and Methodist Hospital of Southern California from 2007 to 2013. Ms. Leslie holds an M.B.A. from Columbia Business School and a B.A. in Economics from Bucknell University.
- Elliott Robinson
-
Elliott Robinson，自2020年2月起担任董事会成员。Robinson先生自2019年3月起担任全球风险投资和私募股权公司Bessemer Venture Partners（“Bessemer”）的合伙人。在加入Bessemer之前，Robinson先生于2016年11月至2019年3月在微软公司的风险投资子公司M12担任合伙人，并于2014年3月至2016年10月在投资公司Georgian Partners担任副总裁。从2006年到2013年，鲁滨逊先生在风险投资公司Syncom Venture Partners担任越来越多的职务。他目前担任多家私营科技、软件和人工智能公司的董事会成员，包括CoActive Systems Inc.、Databook Labs，Inc.、Hyper Labs，Inc.、Imply Data，Inc.和Render Services，Inc.。Robinson先生拥有哥伦比亚商学院的工商管理硕士学位和莫尔豪斯学院的数学学士学位。
Elliott Robinson,has served as a member of board of directors since February 2020. Mr. Robinson has served as a Partner at Bessemer Venture Partners ("Bessemer"), a global venture capital and private equity firm, since March 2019. Prior to joining Bessemer, Mr. Robinson served as a partner at M12, a venture capital subsidiary of Microsoft Corporation, from November 2016 to March 2019, and as a Vice President at Georgian Partners, an investment firm, from March 2014 to October 2016. From 2006 to 2013, Mr. Robinson held roles of increasing responsibility at Syncom Venture Partners, a venture capital firm. He currently serves on the board of directors of several privately held technology, software, and artificial intelligence companies, including Coactive Systems Inc., Databook Labs, Inc., Hyper Labs, Inc., Imply Data, Inc., and Render Services, Inc. Mr. Robinson holds an M.B.A. from Columbia Business School and a B.S. in Mathematics from Morehouse College. - Elliott Robinson，自2020年2月起担任董事会成员。Robinson先生自2019年3月起担任全球风险投资和私募股权公司Bessemer Venture Partners（“Bessemer”）的合伙人。在加入Bessemer之前，Robinson先生于2016年11月至2019年3月在微软公司的风险投资子公司M12担任合伙人，并于2014年3月至2016年10月在投资公司Georgian Partners担任副总裁。从2006年到2013年，鲁滨逊先生在风险投资公司Syncom Venture Partners担任越来越多的职务。他目前担任多家私营科技、软件和人工智能公司的董事会成员，包括CoActive Systems Inc.、Databook Labs，Inc.、Hyper Labs，Inc.、Imply Data，Inc.和Render Services，Inc.。Robinson先生拥有哥伦比亚商学院的工商管理硕士学位和莫尔豪斯学院的数学学士学位。
- Elliott Robinson,has served as a member of board of directors since February 2020. Mr. Robinson has served as a Partner at Bessemer Venture Partners ("Bessemer"), a global venture capital and private equity firm, since March 2019. Prior to joining Bessemer, Mr. Robinson served as a partner at M12, a venture capital subsidiary of Microsoft Corporation, from November 2016 to March 2019, and as a Vice President at Georgian Partners, an investment firm, from March 2014 to October 2016. From 2006 to 2013, Mr. Robinson held roles of increasing responsibility at Syncom Venture Partners, a venture capital firm. He currently serves on the board of directors of several privately held technology, software, and artificial intelligence companies, including Coactive Systems Inc., Databook Labs, Inc., Hyper Labs, Inc., Imply Data, Inc., and Render Services, Inc. Mr. Robinson holds an M.B.A. from Columbia Business School and a B.S. in Mathematics from Morehouse College.
高管简历
中英对照 | 中文 | 英文- Daniel Perez
Daniel Perez，是联合创始人，自2012年1月起担任首席执行官和董事会成员。在加入Hinge Health之前，Perez先生于2011年6月至2016年5月担任全球生物技术研究平台Oxbridge Biotech Roundtable Ltd.的联合创始人兼首席执行官。Perez先生拥有威斯敏斯特大学生物学学士学位。
Daniel Perez,is co-founder and has served as Chief Executive Officer and a member of board of directors since January 2012. Prior to joining Hinge Health, Mr. Perez was the co-founder and Chief Executive Officer at Oxbridge Biotech Roundtable Ltd., a global biotechnology research platform, from June 2011 to May 2016. Mr. Perez holds a B.S. in Biology from Westminster University.- Daniel Perez，是联合创始人，自2012年1月起担任首席执行官和董事会成员。在加入Hinge Health之前，Perez先生于2011年6月至2016年5月担任全球生物技术研究平台Oxbridge Biotech Roundtable Ltd.的联合创始人兼首席执行官。Perez先生拥有威斯敏斯特大学生物学学士学位。
- Daniel Perez,is co-founder and has served as Chief Executive Officer and a member of board of directors since January 2012. Prior to joining Hinge Health, Mr. Perez was the co-founder and Chief Executive Officer at Oxbridge Biotech Roundtable Ltd., a global biotechnology research platform, from June 2011 to May 2016. Mr. Perez holds a B.S. in Biology from Westminster University.
- Jim Pursley
吉姆·珀斯利，自2021年3月起担任总裁。在加入Hinge Health之前，Pursley先生于2014年4月至2020年11月期间担任公众持股的数字健康公司Livongo Health, Inc.的首席商务官。此前，他曾于2011年1月至2014年4月在私营数字健康公司Care Innovations，LLC担任多个高管职务，最近于2012年8月至2014年4月担任销售和营销副总裁。在其职业生涯的早期，Pursley先生曾于2003年至2010年在GE Healthcare技术公司担任越来越重要的职务。Pursley先生拥有西北大学家乐氏管理学院的工商管理硕士学位和宾夕法尼亚州立大学管理科学与信息系统学士学位。
Jim Pursley,has served as President since March 2021. Prior to joining Hinge Health, Mr. Pursley served as the Chief Commercial Officer of Livongo Health, Inc., a publicly held digital health company, from April 2014 to November 2020. Previously, he served in various executive roles at Care Innovations, LLC, a private digital health company, from January 2011 to April 2014, most recently as Vice President, Sales and Marketing from August 2012 to April 2014. Earlier in his career, Mr. Pursley held roles of increasing responsibility at GE HealthCare Technologies Inc. from 2003 to 2010. Mr. Pursley holds an M.B.A. from Kellogg School of Management at Northwestern University and a B.S. in Management Science and Information Systems from Pennsylvania State University.- 吉姆·珀斯利，自2021年3月起担任总裁。在加入Hinge Health之前，Pursley先生于2014年4月至2020年11月期间担任公众持股的数字健康公司Livongo Health, Inc.的首席商务官。此前，他曾于2011年1月至2014年4月在私营数字健康公司Care Innovations，LLC担任多个高管职务，最近于2012年8月至2014年4月担任销售和营销副总裁。在其职业生涯的早期，Pursley先生曾于2003年至2010年在GE Healthcare技术公司担任越来越重要的职务。Pursley先生拥有西北大学家乐氏管理学院的工商管理硕士学位和宾夕法尼亚州立大学管理科学与信息系统学士学位。
- Jim Pursley,has served as President since March 2021. Prior to joining Hinge Health, Mr. Pursley served as the Chief Commercial Officer of Livongo Health, Inc., a publicly held digital health company, from April 2014 to November 2020. Previously, he served in various executive roles at Care Innovations, LLC, a private digital health company, from January 2011 to April 2014, most recently as Vice President, Sales and Marketing from August 2012 to April 2014. Earlier in his career, Mr. Pursley held roles of increasing responsibility at GE HealthCare Technologies Inc. from 2003 to 2010. Mr. Pursley holds an M.B.A. from Kellogg School of Management at Northwestern University and a B.S. in Management Science and Information Systems from Pennsylvania State University.
- Gabriel Mecklenburg
Gabriel Mecklenburg是联合创始人，自2021年2月起担任公司执行主席，自2016年3月起担任董事会成员。他还在2014年10月至2021年2月期间担任首席运营官。2011年12月至2014年5月，梅克伦堡先生担任全球生物技术研究平台Oxbridge Biotech Roundtable Ltd.的首席运营官。自2022年1月以来，他一直担任Digital Therapeutics，Inc.的董事会成员，从事Pelago Health的业务，这是一家私营虚拟护理公司，专注于物质Hinge Health，Inc. e管理。梅克伦堡先生拥有剑桥大学材料科学硕士学位和伦敦帝国理工学院生物工程硕士学位。
Gabriel Mecklenburg,is co-founder and has served as the Executive Chairman of company since February 2021 and a member of board of directors since March 2016. He also served as Chief Operating Officer from October 2014 to February 2021. From December 2011 to May 2014, Mr. Mecklenburg was the Chief Operating Officer at Oxbridge Biotech Roundtable Ltd., a global biotechnology research platform. He has served on the board of directors of Digital Therapeutics, Inc., doing business as Pelago Health, a privately held virtual care company focused on substance Hinge Health, Inc. e management, since January 2022. Mr. Mecklenburg holds an M.Sc. in Materials Science from the University of Cambridge and an M.Phil. in Bioengineering from Imperial College London.- Gabriel Mecklenburg是联合创始人，自2021年2月起担任公司执行主席，自2016年3月起担任董事会成员。他还在2014年10月至2021年2月期间担任首席运营官。2011年12月至2014年5月，梅克伦堡先生担任全球生物技术研究平台Oxbridge Biotech Roundtable Ltd.的首席运营官。自2022年1月以来，他一直担任Digital Therapeutics，Inc.的董事会成员，从事Pelago Health的业务，这是一家私营虚拟护理公司，专注于物质Hinge Health，Inc. e管理。梅克伦堡先生拥有剑桥大学材料科学硕士学位和伦敦帝国理工学院生物工程硕士学位。
- Gabriel Mecklenburg,is co-founder and has served as the Executive Chairman of company since February 2021 and a member of board of directors since March 2016. He also served as Chief Operating Officer from October 2014 to February 2021. From December 2011 to May 2014, Mr. Mecklenburg was the Chief Operating Officer at Oxbridge Biotech Roundtable Ltd., a global biotechnology research platform. He has served on the board of directors of Digital Therapeutics, Inc., doing business as Pelago Health, a privately held virtual care company focused on substance Hinge Health, Inc. e management, since January 2022. Mr. Mecklenburg holds an M.Sc. in Materials Science from the University of Cambridge and an M.Phil. in Bioengineering from Imperial College London.
- James Budge
James Budge，自2023年3月起担任首席财务官。在加入Hinge Health之前，Budge先生于2021年5月至2023年4月担任私营机器人过程自动化公司Automation Anywhere，Inc.的首席财务官。此前，他于2018年5月至2021年4月期间、于2017年4月至2021年5月期间担任在线教育公司Pluralsight, Inc.、财务规划和绩效管理公司Anaplan, Inc.于2016年1月至2017年2月期间担任首席财务官。在加入Anaplan, Inc.之前，他曾于2012年5月至2016年1月在私营联络中心解决方案公司Genesys Cloud Services，Inc.担任首席财务官和首席运营官，并于2005年9月至2012年5月在数字娱乐技术公司Macrovision Solutions Corporation（前身为Macrovision Solutions Corporation）担任TERM1和首席运营官。Budge先生的职业生涯始于会计师事务所普华永道会计师事务所。Budge先生拥有杨百翰大学会计学学士学位。
James Budge,has served as Chief Financial Officer since March 2023. Prior to joining Hinge Health, Mr. Budge was the Chief Financial Officer of Automation Anywhere, Inc., a private robotic process automation company, from May 2021 to April 2023. Previously, he served as the Chief Financial Officer of Pluralsight, Inc., an online education company that was public from May 2018 through April 2021, from April 2017 to May 2021 and Anaplan, Inc., a financial planning and performance management company, from January 2016 to February 2017. Prior to Anaplan, Inc., he served as Chief Financial Officer and Chief Operating Officer at Genesys Cloud Services, Inc., a private contact center solutions company, from May 2012 to January 2016 and Rovi Corporation, previously Macrovision Solutions Corporation, a digital entertainment technology company that was public from March 1997 until September 2016, from September 2005 to May 2012. Mr. Budge began his career at PricewaterhouseCoopers LLP, an accounting firm. Mr. Budge holds a B.S. in Accounting from Brigham Young University.- James Budge，自2023年3月起担任首席财务官。在加入Hinge Health之前，Budge先生于2021年5月至2023年4月担任私营机器人过程自动化公司Automation Anywhere，Inc.的首席财务官。此前，他于2018年5月至2021年4月期间、于2017年4月至2021年5月期间担任在线教育公司Pluralsight, Inc.、财务规划和绩效管理公司Anaplan, Inc.于2016年1月至2017年2月期间担任首席财务官。在加入Anaplan, Inc.之前，他曾于2012年5月至2016年1月在私营联络中心解决方案公司Genesys Cloud Services，Inc.担任首席财务官和首席运营官，并于2005年9月至2012年5月在数字娱乐技术公司Macrovision Solutions Corporation（前身为Macrovision Solutions Corporation）担任TERM1和首席运营官。Budge先生的职业生涯始于会计师事务所普华永道会计师事务所。Budge先生拥有杨百翰大学会计学学士学位。
- James Budge,has served as Chief Financial Officer since March 2023. Prior to joining Hinge Health, Mr. Budge was the Chief Financial Officer of Automation Anywhere, Inc., a private robotic process automation company, from May 2021 to April 2023. Previously, he served as the Chief Financial Officer of Pluralsight, Inc., an online education company that was public from May 2018 through April 2021, from April 2017 to May 2021 and Anaplan, Inc., a financial planning and performance management company, from January 2016 to February 2017. Prior to Anaplan, Inc., he served as Chief Financial Officer and Chief Operating Officer at Genesys Cloud Services, Inc., a private contact center solutions company, from May 2012 to January 2016 and Rovi Corporation, previously Macrovision Solutions Corporation, a digital entertainment technology company that was public from March 1997 until September 2016, from September 2005 to May 2012. Mr. Budge began his career at PricewaterhouseCoopers LLP, an accounting firm. Mr. Budge holds a B.S. in Accounting from Brigham Young University.